设为首页 电子邮箱 联系我们

本刊最新招聘信息请见“通知公告”!  本刊投稿系统试运行中,欢迎投稿!如投稿有问题,可直接将稿件发送至zgyy8888@163.com

 

主管单位:中华人民共和国   

国家卫生健康委员会

主办单位:
总编辑:
杨秋

编辑部主任:吴翔宇

邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)

                  

2018 年第 5 期 第 13 卷

胰岛素强化治疗对急性胰腺炎患者肠黏膜功能及预后的影响

Effect of intensified insulin therapy on intestinal mucosal function and prognosis of patients with acute pancreatitis

作者:李玉鹏刘斌邢成文侯明

英文作者:

单位:810000西宁,青海仁济医院重症医学科(李玉鹏、刘斌、邢成文);810000西宁,青海大学附属医院急救中心(侯明)

英文单位:

关键词:急性胰腺炎;胰岛素;强化治疗;肠黏膜功能

英文关键词:

  • 摘要:
  • 目的    探讨胰岛素强化治疗对急性胰腺炎患者肠黏膜功能及预后的影响。方法    选取2013年 1月至2017年1月青海仁济医院的急性胰腺炎患者50例,采用随机数字表法分为观察组与对照组,各25例。对照组采用常规药物治疗;观察组在对照组基础上采用胰岛素强化治疗。比较2组炎性因子、D-乳酸水平及急性生理学与慢性健康状况评分系统Ⅱ(APACHE Ⅱ)评分的差异。结果    治疗后2组C反应蛋白、白细胞介素8、肿瘤坏死因子α均明显低于治疗前[观察组:(50±15)mg/L比(170±33)mg/L、(33.2±2.7)ng/L比(100.3±16.0)ng/L、(17±5)ng/L比(61±17)ng/L,对照组:(80±18)mg/L比(170±31)mg/L、(51.6±8.6)ng/L比(100.3±15.9)ng/L、(29±6)ng/L比(61±18)ng/L],观察组D-乳酸明显低于治疗前[(1.02±0.16)kU/L比(1.62±0.43)kU/L],且观察组上述指标均明显低于对照组(均P<0.05)。治疗后2组APACHE Ⅱ评分均明显低于治疗前[观察组:(9.6±2.4)分比(26.2±3.1)分,对照组:(14.6±3.1)分比(26.2±3.1)分],且观察组明显低于对照组(均P<0.05)。2组病死率差异无统计学意义(P>0.05)。结论    胰岛素强化治疗可通过明显改善急性胰腺炎患者炎性反应程度,保护肠黏膜功能,最终改善预后状况。

  • 【Abstract】Objective    To explore the effect of intensified insulin therapy on intestinal mucosal function and prognosis of patients with acute pancreatitis. Methods    Fifty patients with acute pancreatitis in Qinghai Renji Hospital from January 2013 to January 2017 were randomly divided into observation group and control group, with 25 cases in each group. The control group had conventional medical treatment; the observation group had intensified insulin therapy on the basis of control group. Levels of inflammatory factors, D-lactate and the Acute Physiology and Chronic Health Evaluation Ⅱ(APACHE Ⅱ) score were analyzed. Results    Levels of C-reactive protein, interleukin-8, tumor necrosis factor-α after treatment were significantly lower than those before treatment in both groups[observation group: (50±15)mg/L vs(170±33)mg/L, (33.2±2.7)ng/L vs (100.3±16.0)ng/L, (17±5)ng/L vs (61±17)ng/L; control group: (80±18)mg/L vs (170±31)mg/L, (51.6±8.6)ng/L vs (100.3±15.9)ng/L, (29±6)ng/L vs (61±18)ng/L]; level of D-lactate after treatment was significantly lower than that before treatment in observation group[(1.02±0.16)kU/L vs (1.62±0.43)kU/L]; levels of C-reactive protein, interleukin-8, tumor necrosis factor-α and D-lactate after treatment in observation were significantly lower than those in control group(P<0.05). The APACHE Ⅱ score after treatment was significantly lower than that before treatment in both groups[observation group: (9.6±2.4)points vs (26.2±3.1)points; control group: (14.6±3.1)points vs (26.2±3.1)points]; the APACHE score after treatment in observation was significantly lower than that in control group(P<0.05). Fatality rate of patients had no significant difference between groups(P>0.05). Conclusion    Intensified insulin therapy treating acute pancreatitis can significantly reduce inflammatory reaction, protect intestinal mucosal function and improve the prognosis.

    【Key words】Acute pancreatitis;Insulin;Intensive treatment;Intestinal mucosal function


copyright
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址: 京ICP备2020043099号-3

当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。







安卓


苹果

关闭
Baidu
map